The correlation between the trajectory of plasma atherosclerosis-inducing index in the examination population and the risk of developing metabolic dysfunction-associated steatotic liver disease - Quiz - MDSpire

The correlation between the trajectory of plasma atherosclerosis-inducing index in the examination population and the risk of developing metabolic dysfunction-associated steatotic liver disease

  • By

  • Yongxin Li

  • Changying Zhao

  • Jun Wang

  • Tao Shi

  • March 31, 2026

  • 0 min

Share

Original Source(s)

The correlation between the trajectory of plasma atherosclerosis-inducing index in the examination population and the risk of developing metabolic dysfunction-associated steatotic liver disease

  • by Yongxin Li, Changying Zhao, Jun Wang, Tao Shi

  • March 31, 2026

Related Content

Comparison of the association and discriminatory ability of CVAI, LAP, CI, and AVI for type 2 diabetes in Chinese adults aged ≥ 50 years: a sex-specific analysis

After the Prescription: The Clinical Support Gap in Telehealth-Based GLP-1 Care

The immunometabolic mechanisms and therapeutic targets of metabolic dysfunction-associated steatohepatitis